| Not Yet Recruiting | To Evaluate the Impact of Smoking on PK After Single-dose Oral Administration of GS1-144 Tablets . Postmenopause | Phase 1 | 2026-05-27 |
| Not Yet Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of GenSci161 in Healthy Adult Participants Healthy Volunteers | Phase 1 | 2026-04-23 |
| Not Yet Recruiting | GS1-144 in Participants With Hepatic Impairment and Healthy Female Hepatic Impairment and Healthy Female | Phase 1 | 2026-04-20 |
| Not Yet Recruiting | A Clinical Study to Evaluate the Absorption, Metabolism, and Excretion of Oral [14C]GS1-144 in Healthy Postmen Healthy Postmenopausal Women, Absorption, Metabolism | Phase 1 | 2026-04-01 |
| Recruiting | A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults. Autoimmune Disease | Phase 1 | 2026-03-16 |
| Not Yet Recruiting | GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or M Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated | Phase 1 | 2026-03-14 |
| Not Yet Recruiting | A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS) Idiopathic Short Stature | Phase 1 / Phase 2 | 2026-03-06 |
| Not Yet Recruiting | A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD) Pediatric Growth Hormone Deficiency | Phase 1 / Phase 2 | 2026-03-06 |
| Not Yet Recruiting | Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately Rheumatoid Arthritis | Phase 2 | 2026-02-01 |
| Not Yet Recruiting | Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma Cachexia, Hepatocellular Carcinoma | Phase 3 | 2026-01-10 |
| Recruiting | A Study（Phase I）of GS3-007a Dry Suspension in Healthy Chinese Adults Healthy Adults | Phase 1 | 2026-01-07 |
| Recruiting | GenSci143 in Participants With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2025-12-20 |
| Not Yet Recruiting | A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD) Adult Growth Hormone Deficiency (AGHD) | Phase 2 | 2025-12-19 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of GenSci140 in Partic Advanced Solid Tumors | Phase 1 | 2025-12-10 |
| Not Yet Recruiting | A First-in-Human Safety and Pharmacokinetic Trial of GenSci142 Administered as Single Ascending Doses in Healt Bacterial Vaginosis | Phase 1 | 2025-12-01 |
| Not Yet Recruiting | A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD) Pediatric Growth Hormone Deficiency | Phase 1 / Phase 2 | 2025-12-01 |
| Recruiting | A Study of GensSci098 in Subjects With Graves' Disease Safety, Tolerability, GenSci098 | Phase 1 | 2025-11-21 |
| Recruiting | GenSci139 in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2025-11-19 |
| Recruiting | A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, an Short Stature Children Born Small for Gestational Age (SGA) | Phase 2 | 2025-11-11 |
| Not Yet Recruiting | Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly Efficacy, Safety, Megestrol Acetate | Phase 1 | 2025-09-29 |
| Recruiting | A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cach Clinical Characteristics and Treatment Outcomes of Malignant Tumor Cachexia, Multicenter Observational Study | Phase 4 | 2025-09-25 |
| Recruiting | A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets Hyperprolactinemia | Phase 3 | 2025-09-12 |
| Recruiting | Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Can Non-small Cell Lung Cancer | Phase 3 | 2025-08-20 |
| Recruiting | Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Inject Rheumatoid Arthritis | Phase 1 | 2025-08-01 |
| Active Not Recruiting | A Study on Bioequivalence of Cabergoline Tablets in Human Body Hyperprolactinemia | Phase 1 | 2025-06-30 |
| Recruiting | A Phase I First-in-Human Study of GenSci128 in Patients With Solid Tumors Harboring a TP53 Y220C Mutation Solid Tumors Harboring a TP53 Y220C Mutation | Phase 1 | 2025-06-10 |
| Recruiting | A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD) Safety, Tolerability, Adult Growth Hormone Deficiency | Phase 1 | 2025-06-09 |
| Not Yet Recruiting | Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia a Metastatic (Stage IV) Non-squamous Non-small Cell Lung Cancer (Nsq-NSCLC) With Driver Gene Negativity, Untreated With Systemic Therapy | Phase 3 | 2025-06-01 |
| Recruiting | A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-related Pain | Phase 2 | 2025-05-26 |
| Not Yet Recruiting | A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations Pediatric Growth Hormone Deficiency (PGHD) | Phase 1 | 2025-05-01 |
| Not Yet Recruiting | Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line E Extensive-stage Small Cell Lung Cancer (ES-SCLC), The Pre-cachexia or Cachexia Patients Who Have Not Received Systemic Treatment and Are Not Eligible for Curative Therapy | Phase 3 | 2025-05-01 |
| Completed | A Bioavailability Study of GS1-144 Tablets in Healthy Postmenopausal Women Healthy Postmenopausal Women | Phase 1 | 2025-04-30 |
| Recruiting | Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors Cachexia, Digestive System Cancer, Gastric Cancer | — | 2025-03-12 |
| Completed | A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci120 in Healthy Adults. Autoimmune Disease | Phase 1 | 2025-02-20 |
| Completed | A Bioequivalence Study of Two Different PEG-rhGH Preparations Pediatric Growth Hormone Deficiency (PGHD) | Phase 1 | 2025-02-10 |
| Recruiting | Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-relate Cancer-related Fatigue， Gastric Cancer，Colorectal Cancer，Nano-crystalline Megestrol Acetate，Megestrol Acetate，First-line Treatment | N/A | 2025-01-23 |
| Recruiting | A Study to Investigate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy With GenSci122 in Parti Advanced Solid Tumor | Phase 1 | 2025-01-08 |
| Not Yet Recruiting | Nano-crystalline Megestrol Acetate for Adjuvant Treatment in High-risk Head and Neck Squamous Cell Carcinoma A Head and Neck Squamous Cell Carcinoma; Underwent Surgery Within 6 Weeks and Postoperative Assessment Indicated High-risk Factors | Phase 3 | 2025-01-01 |
| Withdrawn | Real-World Clinical Study for Malignant Tumor-Induced Cachexia Clinical Characteristics and Treatment Outcomes of Malignant Tumor Cachexia, Multicenter Observational Study | — | 2024-10-15 |
| Completed | Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablets in the Treatment of Moderate to Severe V Vasomotor Syndrome | Phase 2 | 2024-10-14 |
| Recruiting | A Study of GenSci098 in Subjects With Active Thyroid Eye Disease Safety, Tolerability, GenSci098 | Phase 1 | 2024-09-24 |
| Not Yet Recruiting | To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined Wi Idiopathic Hypogonadotropic Hypogonadism | Phase 3 | 2024-09-20 |
| Active Not Recruiting | Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cance Breast Cancer Subjects | Phase 3 | 2024-08-21 |
| Completed | A Bioequivalence Study of Two Different Dosage Form of Genakumab Gouty Arthritis (GA) | Phase 1 | 2024-06-24 |
| Completed | A Bioavailability Study of Two Different PEG-rhGH Preparations. Pediatric Growth Hormone Deficiency (PGHD) | Phase 1 | 2024-05-08 |
| Completed | A Bioequivalence Study of Two Different PEG-rhGH Preparations. Pediatric Growth Hormone Deficiency (PGHD) | Phase 1 | 2024-04-09 |
| Active Not Recruiting | Long-term Follow-up Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant Infertility | — | 2024-03-01 |
| Completed | A Study to Assess Safety and Tolerability of GS1-144 in Healthy Volunteers Vasomotor Symptoms, Adult Healthy Volunteers | Phase 1 | 2024-02-27 |
| Completed | A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Vasomotor System; Labile, Healthy Volunteer | Phase 1 | 2024-01-03 |
| Recruiting | A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, E Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD), Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) | Phase 2 | 2023-12-30 |
| Recruiting | To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Id Active Systemic Juvenile Idiopathic Arthritis | N/A | 2023-12-01 |
| Unknown | A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children Wi GHD | Phase 3 | 2023-12-01 |
| Unknown | A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Grow GHD | Phase 3 | 2023-12-01 |
| Completed | A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations Pediatric Growth Hormone Deficiency (PGHD) | Phase 1 | 2023-11-06 |
| Completed | A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations Pediatric Growth Hormone Deficiency (PGHD) | Phase 1 | 2023-10-31 |
| Unknown | A Study for the Treatment of Dry Eye in Postmenopausal Women Postmenopausal Women With DED | Phase 2 | 2023-09-20 |
| Completed | The Pharmacokinetic and Bioavailability of GenSci094 Before and After a Change in Manufacturing Site Infertility | Phase 1 | 2023-09-19 |
| Completed | Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare Acute Gout, Gout Flare | Phase 2 | 2023-07-21 |
| Completed | A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering Gout, Gout Initiating Urate-loweringUrate-lowering Therapy | Phase 2 | 2023-07-20 |
| Completed | To Evaluate the Safety and Tolerability of Multiple Doses of GS3-007a Oral Solution in Healthy Subjects. Healthy Subject | Phase 1 | 2023-06-19 |
| Completed | To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Reco Infertility | Phase 3 | 2023-03-24 |
| Unknown | To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer. Breast Cancer | Phase 1 | 2023-03-08 |
| Completed | Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy Adults Interstitial Lung Disease | Phase 1 | 2023-03-06 |
| Completed | Safety & Efffficacy of Genakumab in Patients With Frequent Flares Acute Gout Arthritis | Phase 3 | 2023-01-11 |
| Completed | A Real-world Study of Long-acting Growth Hormone Injection for Turner Syndrome Turner Syndrome | — | 2022-11-08 |
| Unknown | A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasi Achondroplasia | Phase 4 | 2022-09-23 |
| Completed | GS3-007a Oral Solution in Healthy Subjects Healthy Subject | Phase 1 | 2022-09-22 |
| Completed | The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advance Advanced Prostate Cancer | Phase 3 | 2022-07-12 |
| Unknown | Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors Malignant Solid Tumors | Phase 1 | 2022-06-07 |
| Unknown | Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma. Adenocarcinoma of Stomach | Phase 3 | 2022-05-30 |
| Completed | A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary Stress Urinary Incontinence | Phase 2 | 2022-01-06 |
| Completed | Clinical Study of Genakumab for Injection in Patients With Acute Gout Acute Gout | Phase 1 / Phase 2 | 2021-05-22 |
| Terminated | Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma Solid Tumor, Non-Hodgkin Lymphoma | Phase 1 | 2021-04-12 |
| Unknown | A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC Metastatic Non-Small Cell Lung Cancer | Phase 1 | 2021-04-02 |
| Terminated | Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome Acute Myelogenous Leukemia, Myelodysplastic Syndromes | Phase 1 | 2021-04-01 |
| Unknown | A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer Advanced Gastric or Gastroesophageal Junction Cancer | Phase 1 / Phase 2 | 2019-08-01 |
| Unknown | Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers Juvenile Idiopathic Arthritis | Phase 1 | 2019-04-22 |
| Unknown | A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due Dwarfism | Phase 3 | 2018-06-25 |
| Unknown | Efficacy and Safety of rhGH (Jintropin®) in Pediatric Participants With ISS Dwarfism | Phase 3 | 2018-06-11 |
| Unknown | A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Pra Prader-Willi Syndrome | Phase 3 | 2018-04-14 |
| Unknown | Pharmacokinetics and Tolerancebility Studies of Gentuximab Injection in the Treatment ofPatients With Late Rec Solid Tumor | Phase 1 | 2017-10-11 |
| Active Not Recruiting | A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Dwarfism | Phase 2 | 2017-05-12 |
| Unknown | A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD Adult Growth Hormone Deficiency | Phase 2 | 2017-04-01 |
| Unknown | Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Defici Growth Retardation | Phase 4 | 2017-03-01 |
| Unknown | Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET Ovarian Hyperstimulation Syndrome | Phase 3 | 2017-03-01 |
| Unknown | A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome Turner Syndrome | Phase 2 | 2016-03-01 |
| Unknown | Effect of Recombinant Human Growth Hormone Injection on the Clinical Outcome of POR in Patients Undergoing IVF Poor Ovarian Response | — | 2016-02-01 |
| Unknown | Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS Polycystic Ovary Syndrome | N/A | 2016-02-01 |
| Unknown | A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature Dwarfism | Phase 2 | 2015-06-01 |
| Active Not Recruiting | Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature Short Stature Children Born Small for Gestational Age (SGA) | Phase 2 | 2015-04-23 |
| Unknown | Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency Growth Hormone Deficiency | Phase 4 | 2015-01-01 |
| Unknown | Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency Growth Hormone Deficiency | Phase 4 | 2015-01-01 |
| Unknown | Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children ( Growth Hormone Deficiency | Phase 4 | 2014-12-01 |
| Unknown | A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Small for Gestational Age Infant | Phase 3 | 2014-12-01 |
| Unknown | Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children Dwarfism, Pituitary | Phase 4 | 2014-11-01 |
| Unknown | Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency Growth Hormone Deficiency | Phase 4 | 2014-11-01 |
| Completed | Efficacy and Safety Study of rhGM-CSF Gel to Treat Deep 2nd Thickness Burn Deep Partial Thickness Burn | Phase 4 | 2010-11-01 |
| Completed | Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Childr Growth Hormone Deficiency | Phase 1 | 2010-03-01 |
| Completed | A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA Small for Gestational Age Infant | Phase 2 | 2009-12-01 |
| Completed | Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovula Anovulation | Phase 3 | 2008-05-01 |
| Completed | Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children Growth Hormone Deficiency | Phase 3 | 2007-03-01 |
| Completed | Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children Growth Hormone Deficiency | Phase 2 | 2006-05-01 |